AVDL
Avadel Pharmaceuticals
AVDL
AVDL
84 hedge funds and large institutions have $527M invested in Avadel Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 33 increasing their positions, 20 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
11% less funds holding
Funds holding: 94 → 84 (-10)
36% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 28
Holders
84
Holding in Top 10
4
Calls
$1.74M
Puts
$1.65M
Top Buyers
| 1 | +$53.6M | |
| 2 | +$20.9M | |
| 3 | +$17.1M | |
| 4 |
SCM
Sarissa Capital Management
Greenwich,
Connecticut
|
+$15.7M |
| 5 |
Millennium Management
New York
|
+$13.2M |
Top Sellers
| 1 | -$21.3M | |
| 2 | -$10.6M | |
| 3 | -$10.2M | |
| 4 |
BC
Broadfin Capital
New York
|
-$7.79M |
| 5 |
MACM
March Altus Capital Management
Greenwich,
Connecticut
|
-$6.76M |